Unknown

Dataset Information

Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.


ABSTRACT: Effective drug development to combat metastatic disease in breast cancer would be aided by the availability of well-characterized preclinical animal models that (a) metastasize with high efficiency, (b) metastasize in a reasonable time-frame, (c) have an intact immune system, and (d) capture some of the heterogeneity of the human disease. To address these issues, we have assembled a panel of twelve mouse mammary cancer cell lines that can metastasize efficiently on implantation into syngeneic immunocompetent hosts. Genomic characterization shows that more than half of the 30 most commonly mutated genes in human breast cancer are represented within the panel. Transcriptomically, most of the models fall into the luminal A or B intrinsic molecular subtypes, despite the predominance of an aggr

SUBMITTER: Yang Y 

PROVIDER: S-EPMC5458155 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature